Indeed, it has been shown that activated GR binds to and represses the enhancer regions of the ER-mediated cell cycle genes’ (e.g., CCND1, CDK2, and CDK6) in ER+ breast cancer cells [28]. This evidence concerns the gene CDK6 and breast carcinoma.